Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Researchers at the University of Waterloo have unlocked the potential of graphene in areas as diverse as vehicles, consumer ...

Coffee Capsules Market Size was valued at $5.9 billion in 2022, and is estimated to reach $11.9 billion by 2032, growing at a CAGR of 7.6% from 2023 ...

Today, Benzinga's options scanner spotted 9 options trades for AstraZeneca. This isn't normal. The overall sentiment of these ...

Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated ...

Welcome to the Adaptive Biotechnologies fourth-quarter and full-year 2024 financial results conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I ...

Anthony Albanese says he will aim to get an exemption for Australia on US tariffs; Super Bowl advertisers play it safe with ...

Diabetic foot screening intervals could be extended beyond 1 year for patients at very low risk for diabetic foot complications.

U.S. flu activity over the last four weeks is also significantly higher when compared to the same time last year.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road. Key Insights Using the 2 Stage Free Cash Flow to Equity, Tandem Diabetes ...

Released on Friday, February 7, the January jobs report showed resilience in the labor market with higher-than-expected wage ...